Revyve, a spin-off from Wageningen University & Research (WUR) and StartLife alumnus, has raised €24 million in Series B funding to accelerate the commercial rollout of functional yeast proteins that replace eggs and additives in mainstream foods. The round brings total funding more than €40 million and positions Revyve to scale global supply.
The round was co-led by ABN AMRO Sustainable Impact Fund and Invest-NL, with regional support from Brabantse Ontwikkelings Maatschappij (BOM) and strategic investments from Lallemand Bio-Ingredients’ Danstar Ferment and Grey Silo Ventures (Cereal Docks Group). Existing investors Oost NL and Royal Cosun, both StartLife partners, increased their commitments.
From First-of-a-Kind Facility to Full Commercial Scale
Revyve launched its first-of-a-kind (FOAK) production facility in Dinteloord in 2024. With commercial volumes proven and customer lines live, the new capital will modularly scale production, broaden applications, and serve larger global accounts across Europe, the UK, the US, Canada, Mexico, and Australia.
Revyve answers three industry challenges: volatile egg pricing, scrutiny of ultra-processed foods, and lower CO₂ footprints. Its clean-label ingredients help brands remove additives while keeping texture, binding, and mouthfeel consumers expect.
“Food manufacturers are cutting back on eggs to offset increasing prices and reach sustainability targets, but replicating their unique functionality is crucial to maintaining the texture and mouthfeel consumers are used to. This funding round marks a tipping point for us: allowing us to modularly scale production and branch out to more food categories and serve our sustainable solutions to larger customers worldwide.” said Cedric Verstraeten, CEO of Revyve.
“This is exactly where our Yeast Proteins come in, providing an affordable and clean label solution for egg replacement or egg reduction” ~ Cedric Verstraeten
Expanding Production Capabilities in the Netherlands
Built in the Wageningen and Brabant ecosystems, Revyve produces natural, price-competitive yeast proteins that perform like eggs in bakery, sauces, alt meat, and plant-based dairy. The company’s first-of-a-kind plant in Dinteloord is already running at capacity for customers; with this round, output will expand to 1,600+ tons per year.
“Strong regional support from both the Wageningen and Brabant ecosystems has enabled us to scale to industrial levels in record time. With a passionate team and strong investor backing, we have an incredibly solid foundation for global expansion.” ~ Cedric Verstraeten
Trusted by Leading Investors
Revyve’s €24M Series B signals high confidence in its proprietary yeast protein platform and commercial potential. The round brings together institutional, public, and strategic investors with deep expertise in food, and scaling production.
“We are excited to partner with Revyve as they pioneer pressing sustainable alternatives to traditional egg ingredients. Their solution addresses a critical need in the food transition: scalable ingredients with a low environmental footprint and compelling economics for food manufacturers. We believe this combination of commercial viability and measurable sustainable benefits makes Revyve uniquely positioned to grow into a global leader. We look forward to supporting their journey.” said Hanna Zwietering, ABN AMRO SIF Senior Investment Manager.
Lisette Kersting-van der Boog, Senior Investment Manager of Invest-NL adds: “With their functional egg-replacement ingredients, Revyve can play a major role in accelerating the global protein transition and fostering circular solutions that reduce pressure on land, water and animals. We are proud to invest in this Dutch company, which strengthens the country’s innovative power with a pioneering technology that has the potential to transform food production worldwide.”
Ingrid Nieweg, Investment Manager at BOM concludes: “Revyve’s plans align seamlessly with our mission to position Brabant as the Scale-Up Plant of Europe. Their breakthrough technology not only contributes to a more sustainable food system but also exemplifies the kind of bold innovation we aim to foster in the region. We’re proud to support Revyve in scaling their impact from Brabant to the world.”
Lallemand Bio-Ingredients and Grey Silo Ventures complete Revyve’s Series B round, bringing a wealth of knowledge and synergies in yeast innovation and agri-food expertise.
StartLife’s Early Support
Revyve’s journey with StartLife began in 2019, when they joined our Accelerate program under the name Fumi Ingredients and received StartLife pre-seed funding. This early support laid the foundation for their validation efforts and first industry connections.
Through fast-tracked market discovery, pilots, and investor-readiness support, followed by pre-seed funding to drive execution, StartLife backed Revyve from proof of concept to first production steps. We are proud to have supported them at the foundation of their scaling journey.
